Opportunity Information: Apply for RFA DA 22 029
The grant opportunity titled "Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required)" (Funding Opportunity Number RFA-DA-22-029) is a discretionary NIH research grant designed to fund early-stage, developmental, and exploratory projects that clarify the basic neurobiological mechanisms connecting sleep and substance use disorders (SUDs). The central focus is on mechanistic science: research that can explain how disruptions in sleep regulation and the neurobiology of addiction influence one another in both directions. The goal is not just to document that sleep problems and SUDs co-occur, but to identify the underlying processes that tie them together, including how sleep changes may increase vulnerability to substance use, and how substance use may alter sleep-wake systems in ways that worsen addiction risk, relapse likelihood, or recovery outcomes.
A defining feature of this opportunity is that it uses the R61/R33 phased innovation award structure and requires basic experimental studies with humans. In practice, that means the funding mechanism is intended to support a high-impact, exploratory first phase (R61) that can establish feasibility and generate strong initial mechanistic evidence, followed by a second phase (R33) that expands or deepens the work once early milestones are met. Because the FOA specifies human basic experimental studies, applicants are expected to include experimental manipulation or closely controlled mechanistic approaches in human participants rather than relying solely on observational or correlational designs. The scientific emphasis is on neurobiology and sleep regulation as they relate to SUD mechanisms, which can include investigating brain circuits, neurochemical systems, behavioral and cognitive processes, or physiological pathways that plausibly explain the sleep-SUD connection.
The program rationale highlights practical downstream value even though the work is framed as basic research. By mapping the mechanisms that link sleep and addiction-related processes, the research is expected to generate insights relevant to preventing SUDs, managing risk, and identifying novel targets for therapeutics. In other words, the studies should help explain fundamental cause-and-effect pathways that could eventually inform new interventions, such as strategies that address sleep disruption to reduce substance use risk, or addiction treatments that reduce sleep-related triggers for craving and relapse. The FOA also emphasizes the bidirectional nature of the relationship: sleep problems may contribute to SUD development or persistence, and SUDs may produce or worsen sleep dysregulation, creating self-reinforcing cycles that are important to understand at a mechanistic level.
Eligibility is broad and includes many types of organizations that can conduct biomedical and behavioral research. Eligible applicants listed in the source data include state, county, and local governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized governments; public housing authorities/Indian housing authorities; nonprofits with and without 501(c)(3) status (excluding institutions of higher education in those nonprofit categories); for-profit organizations (other than small businesses); and small businesses. The FOA also explicitly calls out additional eligible applicants such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISI), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), faith-based or community-based organizations, eligible federal agencies, U.S. territories or possessions, regional organizations, and non-domestic (non-U.S.) entities (foreign organizations). This wide eligibility suggests NIH is open to a diverse set of institutions and research settings, including community-linked organizations and international partners where appropriate.
From an administrative standpoint, the opportunity is offered by the National Institutes of Health and is categorized under Education and Health, with CFDA number 93.279. The original closing date shown is 2021-10-14, and the opportunity was created on 2021-06-28. The listed award ceiling is $250,000, indicating the FOA places an upper bound on the size of awards (as presented in the source summary). The number of expected awards is not specified in the provided data. Overall, the funding announcement is aimed at catalyzing rigorous, human-focused mechanistic research that can illuminate how sleep biology and substance use pathology intersect, with the longer-term promise of improving prevention and treatment strategies by targeting the core processes that connect these two major public health issues.Apply for RFA DA 22 029
- The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "Exploratory Studies to Investigate the Mechanisms of Interrelationship between Sleep and Substance Use Disorders (R61/R33 Basic Experimental Studies with Humans Required)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
- This funding opportunity was created on 2021-06-28.
- Applicants must submit their applications by 2021-10-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $250,000.00 in funding.
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Browse more opportunities from the same category: Education, Health
Next opportunity: Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed)
Previous opportunity: Cooperative Agreement for CESU-affiliated Partner with Colorado Plateau Cooperative Ecosystem Studies Unit
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for RFA DA 22 029
Applicants also applied for:
Applicants who have applied for this opportunity (RFA DA 22 029) also looked into and applied for these:
| Funding Opportunity |
|---|
| Understanding Oral Human Papillomavirus (HPV) Infection, Acquisition, and Persistence in People Living with HIV (R01 Clinical Trial Not Allowed) Apply for RFA DE 22 003 Funding Number: RFA DE 22 003 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R01 Clinical Trial Not Allowed) Apply for RFA DA 22 031 Funding Number: RFA DA 22 031 Agency: National Institutes of Health Category: Education, Health Funding Amount: $400,000 |
| HEAL Initiative: Novel Targets for Opioid Use Disorders and Opioid Overdose (R21 Clinical Trial Not Allowed) Apply for RFA DA 22 032 Funding Number: RFA DA 22 032 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Metabolic Dysregulation and Cancer Risk Program, Research Grants: a Transdisciplinary Approach to Obesity-Associated Research (U01 Clinical Trial Optional) Apply for RFA CA 21 021 Funding Number: RFA CA 21 021 Agency: National Institutes of Health Category: Education, Health Funding Amount: $850,000 |
| Growing Great Ideas: Research Education Course in Product Development and Entrepreneurship for Life Science Researchers (UE5 Clinical Trial Not Allowed) Apply for RFA DA 22 020 Funding Number: RFA DA 22 020 Agency: National Institutes of Health Category: Education, Health Funding Amount: $320,000 |
| Coordinating Center for the Metabolic Dysregulation and Cancer Risk Program: A Transdisciplinary Approach to Obesity-Associated Cancer Research (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 022 Funding Number: RFA CA 21 022 Agency: National Institutes of Health Category: Education, Health Funding Amount: $550,000 |
| Innate Immune Memory Impacting HIV Acquisition and/or Control (R21 Clinical Trial Not Allowed) Apply for RFA AI 21 041 Funding Number: RFA AI 21 041 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Exploiting in Vivo or in Situ Imaging Approaches to Understand HIV-relevant Processes In The Context of Substance Use Disorders (R61/R33 Clinical Trials Optional) Apply for RFA DA 23 001 Funding Number: RFA DA 23 001 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Technology Development for Single-Molecule Protein Sequencing (R43/R44 Clinical Trial not allowed) Apply for PAR 21 247 Funding Number: PAR 21 247 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Data and Resource Coordination Center (CAP-IT DRCC) (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 039 Funding Number: RFA CA 21 039 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Centers (U54 Clinical Trial Not Allowed) Apply for RFA CA 21 038 Funding Number: RFA CA 21 038 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) Apply for PAR 21 287 Funding Number: PAR 21 287 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Apply for PAR 21 290 Funding Number: PAR 21 290 Agency: National Institutes of Health Category: Education, Health Funding Amount: $500,000 |
| Pancreatic Ductal Adenocarcinoma Stromal Reprogramming Consortium Coordinating and Data Management Center (PSRC CDMC) (U24 Clinical Trial Not Allowed) Apply for RFA CA 21 042 Funding Number: RFA CA 21 042 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| Pancreatic Ductal Adenocarcinoma (PDAC) Stromal Reprogramming Consortium (PSRC) (U01 Clinical Trial Not Allowed) Apply for RFA CA 21 041 Funding Number: RFA CA 21 041 Agency: National Institutes of Health Category: Education, Health Funding Amount: $600,000 |
| NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 21 285 Funding Number: PAR 21 285 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) Apply for RFA DA 22 033 Funding Number: RFA DA 22 033 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) Apply for PAR 21 294 Funding Number: PAR 21 294 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| NCI Research Specialist (Core-based Scientist) Award (R50 Clinical Trial Not Allowed) Apply for PAR 21 286 Funding Number: PAR 21 286 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
| Canine Cancer Immunotherapy Network (K9CIN; U01 Clinical Trial Not Allowed) Apply for RFA CA 21 050 Funding Number: RFA CA 21 050 Agency: National Institutes of Health Category: Education, Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "RFA DA 22 029", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
